IX1 Analyst Ratings
Moderate Buy
4 Buy
4 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
IX1 Stock 12 Month Forecast
Average Price Target
―| Highest Price TargetCHF669.88 | Average Price TargetCHF581.82 | Lowest Price TargetCHF553.38 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
KeyBanc
―
Hold
―
Initiated
10/12/26
William Blair
―
Buy
―
Reiterated
10/02/26
UBS
CHF557.54
Hold
―
Assigned
09/16/26
Bank of America Securities
CHF549.22→CHF553.38
Hold
―
Reiterated
08/14/26
Stifel Nicolaus
CHF561.7
Buy
―
Reiterated
08/14/26
Barclays
CHF590.83
Buy
―
Reiterated
08/11/26
Morgan Stanley
CHF669.88
Buy
―
Reiterated
08/05/26
Citi
CHF540.9→CHF557.54
Hold
―
Reiterated
08/05/26
Jefferies
CHF659.07
Buy
―
Reiterated
05/06/26
Piper Sandler
CHF644.92→CHF624.12
Hold
―
Reiterated
02/09/26
BTIG
CHF690.69→CHF665.72
Buy
―
Reiterated
02/03/26
J.P. Morgan
CHF644.92
Buy
―
Reiterated
11/03/25
Leerink Partners
CHF619.96→CHF653.24
Buy
―
Reiterated
11/03/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
KeyBanc
―
Hold
―
Initiated
10/12/26
William Blair
―
Buy
―
Reiterated
10/02/26
UBS
CHF557.54
Hold
―
Assigned
09/16/26
Bank of America Securities
CHF549.22→CHF553.38
Hold
―
Reiterated
08/14/26
Stifel Nicolaus
CHF561.7
Buy
―
Reiterated
08/14/26
Barclays
CHF590.83
Buy
―
Reiterated
08/11/26
Morgan Stanley
CHF669.88
Buy
―
Reiterated
08/05/26
Citi
CHF540.9→CHF557.54
Hold
―
Reiterated
08/05/26
Jefferies
CHF659.07
Buy
―
Reiterated
05/06/26
Piper Sandler
CHF644.92→CHF624.12
Hold
―
Reiterated
02/09/26
BTIG
CHF690.69→CHF665.72
Buy
―
Reiterated
02/03/26
J.P. Morgan
CHF644.92
Buy
―
Reiterated
11/03/25
Leerink Partners
CHF619.96→CHF653.24
Buy
―
Reiterated
11/03/25
Best Analysts Covering Idexx Laboratories
3 Months
Success Rate
7/9 ratings generated profit
Average Return
+7.60%
Copying Daniel Clark's trades and holding each position for 3 Months would result in 77.78% of your transactions generating a profit, with an average return of +7.60% per trade.
1 Year
Success Rate
7/10 ratings generated profit
Average Return
+21.86%
Copying Mark Massaro's trades and holding each position for 1 Year would result in 70.00% of your transactions generating a profit, with an average return of +21.86% per trade.
2 Years
Success Rate
7/10 ratings generated profit
Average Return
+6.99%
Copying Mark Massaro's trades and holding each position for 2 Years would result in 70.00% of your transactions generating a profit, with an average return of +6.99% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
IX1 Analyst Recommendation Trends
Rating
Jun 26
Jul 26
Aug 26
Sep 26
Oct 26
Strong Buy
0
0
0
0
0
Buy
5
6
7
7
6
Hold
5
3
5
6
5
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
10
9
12
13
11
Each month's total comprises the sum of three months' worth of ratings.
IX1 Financial Forecast
IX1 Stock Forecast FAQ
What is CH:IX1’s average 12-month price target, according to analysts?
Based on analyst ratings, Idexx Laboratories’s 12-month average price target is 581.82.
What is CH:IX1’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for CH:IX1, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Idexx Laboratories a Buy, Sell or Hold?
Idexx Laboratories has a consensus rating of Moderate Buy, which is based on 4 buy ratings, 4 hold ratings and 0 sell ratings.
What is Idexx Laboratories’s share price target?
The average share price target for Idexx Laboratories is 581.82. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is CHF669.88 ,and the lowest forecast is CHF553.38. The average share price target represents N/A Increase from the current price of N/A.
The highest analyst share price target is CHF669.88 ,and the lowest forecast is CHF553.38. The average share price target represents N/A Increase from the current price of N/A.
What do analysts say about Idexx Laboratories?
Idexx Laboratories’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 8 Wall Streets Analysts.
How can I buy shares of Idexx Laboratories?
To buy shares of CH:IX1, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.